Equity Overview
Price & Market Data
Price: $0.0012
Daily Change: -$0.0038 / 316.7%
Range: $0.0012 - $0.0012
Market Cap: $1,001,344
Volume: 543
Performance Metrics
1 Week: 268.6%
1 Month: 115.0%
3 Months: 115.0%
6 Months: 115.0%
1 Year: 158.0%
YTD: -35.50%
Details
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company develops ImMucin, a MUC1 SP-derived vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. It is also developing SP-based COVID-19 and tuberculosis vaccine/treatment candidate. The company was founded in 2006 and is headquartered in Toronto, Canada.